157 related articles for article (PubMed ID: 3087971)
1. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
Grabowski GA; Osiecki-Newman K; Dinur T; Fabbro D; Legler G; Gatt S; Desnick RJ
J Biol Chem; 1986 Jun; 261(18):8263-9. PubMed ID: 3087971
[TBL] [Abstract][Full Text] [Related]
2. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
[TBL] [Abstract][Full Text] [Related]
3. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
[TBL] [Abstract][Full Text] [Related]
4. Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites.
Osiecki-Newman K; Legler G; Grace M; Dinur T; Gatt S; Desnick RJ; Grabowski GA
Enzyme; 1988; 40(4):173-88. PubMed ID: 3234317
[TBL] [Abstract][Full Text] [Related]
5. Gaucher disease types 1, 2, and 3: differential mutations of the acid beta-glucosidase active site identified with conduritol B epoxide derivatives and sphingosine.
Grabowski GA; Dinur T; Osiecki KM; Kruse JR; Legler G; Gatt S
Am J Hum Genet; 1985 May; 37(3):499-510. PubMed ID: 4003396
[TBL] [Abstract][Full Text] [Related]
6. Human lysosomal beta-glucosidase: kinetic characterization of the catalytic, aglycon, and hydrophobic binding sites.
Grabowski GA; Gatt S; Kruse J; Desnick RJ
Arch Biochem Biophys; 1984 May; 231(1):144-57. PubMed ID: 6426391
[TBL] [Abstract][Full Text] [Related]
7. Human acid beta-glucosidase: isolation and amino acid sequence of a peptide containing the catalytic site.
Dinur T; Osiecki KM; Legler G; Gatt S; Desnick RJ; Grabowski GA
Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1660-4. PubMed ID: 3456607
[TBL] [Abstract][Full Text] [Related]
8. Genetic heterogeneity in Gaucher disease: physicokinetic and immunologic studies of the residual enzyme in cultured fibroblasts from non-neuronopathic and neuronopathic patients.
Grabowski GA; Goldblatt J; Dinur T; Kruse J; Svennerholm L; Gatt S; Desnick RJ
Am J Med Genet; 1985 Jul; 21(3):529-49. PubMed ID: 3927728
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
[TBL] [Abstract][Full Text] [Related]
10. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F.
Legler G; Bieberich E
Arch Biochem Biophys; 1988 Jan; 260(1):437-42. PubMed ID: 3124752
[TBL] [Abstract][Full Text] [Related]
11. In vivo inactivation of glycosidases by conduritol B epoxide and cyclophellitol as revealed by activity-based protein profiling.
Kuo CL; Kallemeijn WW; Lelieveld LT; Mirzaian M; Zoutendijk I; Vardi A; Futerman AH; Meijer AH; Spaink HP; Overkleeft HS; Aerts JMFG; Artola M
FEBS J; 2019 Feb; 286(3):584-600. PubMed ID: 30600575
[TBL] [Abstract][Full Text] [Related]
12. Effect of a heat-stable factor in human placenta on glucosylceramidase, glucosylsphingosine glucosyl hydrolase, and acid beta-glucosidase activities.
Vaccaro AM; Muscillo M; Tatti M; Salvioli R; Gallozzi E; Suzuki K
Clin Biochem; 1987 Dec; 20(6):429-33. PubMed ID: 3124976
[TBL] [Abstract][Full Text] [Related]
13. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
Grace ME; Graves PN; Smith FI; Grabowski GA
J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
[TBL] [Abstract][Full Text] [Related]
14. Human acid beta-glucosidase: affinity purification of the normal placental and Gaucher disease splenic enzymes on N-alkyl-deoxynojirimycin-sepharose.
Osiecki-Newman KM; Fabbro D; Dinur T; Boas S; Gatt S; Legler G; Desnick RJ; Grabowski GA
Enzyme; 1986; 35(3):147-53. PubMed ID: 2944742
[TBL] [Abstract][Full Text] [Related]
15. Studies on human acid beta-glucosidase and the nature of the molecular defect in type 1 Ashkenazi Gaucher disease.
Gatt S; Dinur T; Desnick RJ
Prog Clin Biol Res; 1982; 95():315-31. PubMed ID: 6812076
[No Abstract] [Full Text] [Related]
16. Effectors of three beta-glucosidases from human liver.
Daniels LB; Gnarra JR; Glew RH
Prog Clin Biol Res; 1982; 95():333-55. PubMed ID: 6812077
[TBL] [Abstract][Full Text] [Related]
17. A revised fluorometric assay for Gaucher's disease using conduritol-beta-epoxide with liver as the source of Beta-glucosidase.
Daniels LB; Glew RH; Radin NS; Vunnam RR
Clin Chim Acta; 1980 Sep; 106(2):155-63. PubMed ID: 6773704
[TBL] [Abstract][Full Text] [Related]
18. X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease.
Premkumar L; Sawkar AR; Boldin-Adamsky S; Toker L; Silman I; Kelly JW; Futerman AH; Sussman JL
J Biol Chem; 2005 Jun; 280(25):23815-9. PubMed ID: 15817452
[TBL] [Abstract][Full Text] [Related]
19. beta-Glucosidase inhibition in murine peritoneal macrophages by conduritol-B-epoxide: an in vitro model of the Gaucher cell.
Newburg DS; Yatziv S; McCluer RH; Raghavan S
Biochim Biophys Acta; 1986 Jun; 877(1):121-6. PubMed ID: 3087427
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the phospholipid requirement of a rat liver beta-glucosidase.
Basu A; Glew RH
Biochem J; 1984 Dec; 224(2):515-24. PubMed ID: 6517862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
